These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14200096

  • 1. RELATIONSHIP OF THE ADENOVIRUS ERYTHROCYTE-RECEPTOR-MODIFYING FACTOR TO THE TYPE-SPECIFIC COMPLEMENT-FIXING ANTIGEN.
    KASEL JA, HUBER M.
    Proc Soc Exp Biol Med; 1964 May; 116():16-8. PubMed ID: 14200096
    [No Abstract] [Full Text] [Related]

  • 2. HUMAN ADENOVIRUS TYPE 31. A NEW SEROTYPE WITH ONCOGENIC PROPERTIES.
    PEREIRA MS, PERIERA HG, CLARKE SK.
    Lancet; 1965 Jan 02; 1(7375):21-3. PubMed ID: 14246675
    [No Abstract] [Full Text] [Related]

  • 3. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA.
    RAFAJKO RR.
    Am J Hyg; 1964 May 02; 79():310-9. PubMed ID: 14159950
    [No Abstract] [Full Text] [Related]

  • 4. STUDIES ON ADENOVIRUS-12. I. QUANTITATIVE CORRELATIONS BETWEEN SOME PHYSICAL, ANTIGENIC AND INFECTIOUS PROPERTIES.
    SMITH KO.
    J Immunol; 1965 Jun 02; 94():976-89. PubMed ID: 14321442
    [No Abstract] [Full Text] [Related]

  • 5. IN VITRO TRANSFORMATION OF HAMSTER KIDNEY CELLS BY HUMAN ADENOVIRUS TYPE 12.
    MCBRIDE WD, WIENER A.
    Proc Soc Exp Biol Med; 1964 Apr 02; 115():870-4. PubMed ID: 14166590
    [No Abstract] [Full Text] [Related]

  • 6. [COMPARATIVE EVOLUTION OF HEMAGGLUTINATION-INHIBITING, COMPLEMENT-FIXING AND NEUTRALIZING ANTIBODIES DURING AN EPIDEMIC DUE TO ADENOVIRUS 7A].
    HENRY M, SOHIER R, CHARDONNET Y.
    Ann Inst Pasteur (Paris); 1965 Feb 02; 108():180-95. PubMed ID: 14308777
    [No Abstract] [Full Text] [Related]

  • 7. PRODUCTION OF SV-40 COMPLEMENT-FIXING ANTIGEN.
    SCHELL KR.
    Nature; 1964 Jul 25; 203():417-8. PubMed ID: 14197394
    [No Abstract] [Full Text] [Related]

  • 8. THE INCORPORATION OF SV40 MATERIAL INTO ADENOVIRUS 7 AS MEASURED BY INTRANUCLEAR SYNTHESIS OF SV40 TUMOR ANTIGEN.
    RAPP F, MELNICK JL, BUTEL JS, KITAHARA T.
    Proc Natl Acad Sci U S A; 1964 Dec 25; 52(6):1348-52. PubMed ID: 14243507
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.
    WILCOX WC, GINSBERG HS.
    Proc Soc Exp Biol Med; 1963 Oct 25; 114():37-42. PubMed ID: 14076907
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A HOSPITAL EPIDEMIC OF KERATOCONJUNCTIVITIS CAUSED BY ADENOVIRUS TYPE 7 IN HELSINKI.
    TOMMILA V, LAPINLEIMU K.
    Acta Ophthalmol (Copenh); 1965 Oct 25; 43():294-8. PubMed ID: 14293652
    [No Abstract] [Full Text] [Related]

  • 17. A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.
    SCHMIDT NJ, LENNETTE EH, SHON CW, SHINOMOTO TT.
    Proc Soc Exp Biol Med; 1964 May 25; 116():144-9. PubMed ID: 14200088
    [No Abstract] [Full Text] [Related]

  • 18. SPECIFIC COMPLEMENT-FIXING TUMOR ANTIGENS IN HUMAN CELLS MORPHOLOGICALLY TRANSFORMED BY SV40 VIRUS.
    SABIN AB, SHEIN HM, KOCH MA, ENDERS JF.
    Proc Natl Acad Sci U S A; 1964 Dec 25; 52(6):1316-8. PubMed ID: 14243502
    [No Abstract] [Full Text] [Related]

  • 19. AN INCOMPLETE CYCLE OF ADENOVIRUS TYPE 4 MULTIPLICATION IN CANINE CELL CULTURES AND IN DOGS.
    CARMICHAEL LE.
    Am J Vet Res; 1965 Jan 25; 26():15-23. PubMed ID: 14266923
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.